|
Volumn 9, Issue 14, 1998, Pages 2121-2133
|
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUTRALIZING ANTIBODY;
THYMIDINE KINASE;
VIRUS ANTIBODY;
VIRUS PROTEIN;
ADENOVIRUS;
ADULT;
AGED;
ANTIBODY RESPONSE;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EXPRESSION VECTOR;
FEMALE;
GENE THERAPY;
HERPES SIMPLEX VIRUS;
HUMAN;
HUMAN CELL;
HUMORAL IMMUNITY;
MALE;
MESOTHELIOMA;
MONONUCLEAR CELL;
PHASE 1 CLINICAL TRIAL;
SUICIDE GENE;
TRANSGENE;
VIRUS IMMUNITY;
ADENOVIRIDAE;
HERPES;
SIMPLEXVIRUS;
|
EID: 17344366044
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/hum.1998.9.14-2121 Document Type: Article |
Times cited : (197)
|
References (7)
|